A cross-sectional study using the surveillance, epidemiology, and end results program database to estimate the prevalence of Myelodysplastic Syndrome (MDS) in the United States
Hematology, Transfusion and Cell Therapy · 2026-10 · 48 (4) · 106507
DOI: 10.1016/j.htct.2026.106507 ↗Kurz gefasst
Leserbrief in der Zeitschrift Hematology, Transfusion and Cell Therapy, 2026-10. Verfasst von Shangyi Fu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, USA. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Texas Tech University Health Sciences Center.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Dermatology, Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, USA.
- Full Stack Software Engineer, United Airlines, Houston, TX, USA.
- Texas Tech University Health Sciences Center School of Medicine, Lubbock, TX, USA. Electronic address: milcah.poothakary@ttuhsc.edu.
Förderung
- Texas Tech University Health Sciences Center
Zitieren
APA
Fu, S., Huynh, D., & Poothakary, M. (2026). A cross-sectional study using the surveillance, epidemiology, and end results program database to estimate the prevalence of Myelodysplastic Syndrome (MDS) in the United States. Hematology, Transfusion and Cell Therapy, 48(4), 106507. https://doi.org/10.1016/j.htct.2026.106507
Vancouver
Fu S, Huynh D, Poothakary M. A cross-sectional study using the surveillance, epidemiology, and end results program database to estimate the prevalence of Myelodysplastic Syndrome (MDS) in the United States. Hematology, Transfusion and Cell Therapy. 2026;48(4):106507. doi:10.1016/j.htct.2026.106507
BibTeX
@article{Fu2026,
author = {Fu, Shangyi and Huynh, Danny and Poothakary, Milcah},
title = {A cross-sectional study using the surveillance, epidemiology, and end results program database to estimate the prevalence of Myelodysplastic Syndrome (MDS) in the United States},
journal = {Hematology, Transfusion and Cell Therapy},
year = {2026},
volume = {48},
number = {4},
pages = {106507},
doi = {10.1016/j.htct.2026.106507}
}
EUVIMED